C4 Therapeutics, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2025
Total Assets: $359.1M
Liabilities Breakdown FY2025
Total Liabilities: $102.5M
Asset Breakdown
Total Assets: $359.1M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $74.6M | 20.8% |
| Accounts Receivable | $2.4M | 0.7% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $4.7M | 1.3% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $277.3M | 77.2% |
Liabilities Breakdown
Total Liabilities: $102.5M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $858.0K | 0.8% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $101.6M | 99.2% |